Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets
Date:8/11/2009

DETROIT, Aug. 11 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched sumatriptan succinate tablets on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma), immediately following Sun Pharma's recently received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Imitrex(R) tablets. These sumatriptan succinate tablets, 25 mg (base), 50 mg (base) and 100 mg (base) are therapeutically equivalent to Imitrex(R) tablets from GlaxoSmithKline. Sumatriptan succinate tablets are indicated for the acute treatment of migraine attacks with or without aura in adults.

Imitrex(R) is a registered trademark of GlaxoSmithKline.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
5. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... Baltimore (PRWEB) , ... August 05, 2015 , ... ... Nivel Siete, Remote-Learner and Blackboard’s open source companies (Moodlerooms, NetSpot and Remote-Learner UK) ... to formulate common standards and guidelines that will improve and streamline the process ...
(Date:8/5/2015)... ... , ... Jvion’s CEO, Shantanu Nigam , was named Readers’ choice: 21 ... designation is given to those leaders who are enabling innovation within healthcare IT. Shantanu ... firm’s clinical predictive analytic solutions. , A spokesperson for Jvion said, “Since our inception, ...
(Date:8/5/2015)... , ... August 05, 2015 , ... ... of $5.1 Billion by 2020, signifying a firm annualized growth of 11.7% between ... experiencing a steady growth due to increasing demand of ceramic membranes technologies and ...
(Date:8/5/2015)... ... , ... The June 6 opening of Chicago’s new elevated trail, the 606, has been getting ... a group of walkers at Sedgebrook senior living community in Lincolnshire. Known as the ... preserves and twice per month to more distant places. When they read about the ...
(Date:8/5/2015)... ... ... What language does a body speak? "Body Language – from Head to Toe" ... contain the name of a body part. , The use of body part-related expressions ... and expressions, for example, “back against the wall,” “brainstorming,” “sweet tooth,” and “tongue in ...
Breaking Medicine News(10 mins):Health News:Moodle Service Providers to Simplify Moodle Plugin Development 2Health News:Moodle Service Providers to Simplify Moodle Plugin Development 3Health News:Moodle Service Providers to Simplify Moodle Plugin Development 4Health News:Jvion’s Shantanu Nigam Named One of the 21 Health IT Leaders to Know 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 2Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 3Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 4Health News:Ceramic Membrane Market to Grow at a CAGR of 11.7% to 2020 5Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 2Health News:Sedgebrook Trailblazers Tread New Ground on Chicago’s New 606 Path 3Health News:Harvard Medical Professor Dr. Per-Olof Hasselgren Pens Unique Book Using Body Part Idioms 2
... Chico,s (NYSE: CHS ) is thrilled to ... the American Heart Association,s mission to prevent cardiovascular disease ... 2009, Chico,s committed to donate $2.82 from each sale ... Heart Association (AHA) in support of its Start! Movement, ...
... Month and groups across the country and around the globe ... awareness period. The purpose of Men,s Health Month is ... early detection and treatment of disease among men and boys. ... 15-21, the week ending on Father,s Day, a special awareness ...
... been babies, adults have crooned lullabies to soothe them. But ... suckle better and reduce their pain. , If confirmed, this ... babies feed on their own faster and move them out ... clinical professor in the Faculty of Medicine & Dentistry,s Department ...
... study is the first to show that there is ... disease in the general U.S. adult population. This work ... in highly-exposed chemical workers. The study is being presented ... ), the largest international gathering of physicians and researchers ...
... Orthodox Jewish School in Northeast Philadelphia , ... Philadelphia, ... largest medical assistance managed care organization in Pennsylvania, will hold a ... a new, safe playground at Politz Hebrew Academy, an Orthodox Jewish ...
... Advance Health Care Investment OpportunitiesCHICAGO, May 29 ... private equity firm focused exclusively on the health care ... to join the firm as a partner, effective July ... Mr. Womsley, 45, will work with Water Street,s team ...
Cached Medicine News:Health News:Chico's Raises $200K for the American Heart Association 2Health News:Join Men's Health Network in Celebration of Men's Health Month 2Health News:Join Men's Health Network in Celebration of Men's Health Month 3Health News:Music may improve feeding, reduce pain in premature babies: U of A study 2Health News:Environmental pollution increases the risk of liver disease 2Health News:Groundbreaking for Safe Playground Build at Politz Hebrew Academy 2Health News:Citi Private Equity Executive Joins Water Street Healthcare Partners 2Health News:Citi Private Equity Executive Joins Water Street Healthcare Partners 3
(Date:8/4/2015)... SYDNEY and SOUTHAMPTON , ... -- Australian pharmaceutical company Pharmaxis Ltd (ASX: PXS) and UK biotechnology ... into a research collaboration to develop a selective inhibitor to ... fatal lung disease idiopathic pulmonary fibrosis (IPF). ... US. Current products are expected to produce global revenues in ...
(Date:8/4/2015)... VIEW, Calif. , Aug. 4, 2015  IRIDEX ... James H. Mackaness , who had served as chief ... since 2012, has resigned his positions with the Company, ... officer position at another company. Mr. Mackaness intends to ... Company,s second quarter earnings announcement and 10-Q filing. ...
(Date:8/4/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... ended June 30, 2015 and provided a summary ... second quarter of 2015 and recent period marked ... Paul Grint, M.D., President and CEO of Regulus. ...
Breaking Medicine Technology:Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3IRIDEX Chief Financial Officer Resigns to Accept Another Opportunity 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 2Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 3Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 4Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 5Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 6Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 7Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 8Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 9Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights 10
... Reaffirms Primacy and Safety of ,First Generation, Antisense, ... (Nasdaq: GNTA ) announced the presentation of ... lead anticancer,compound, can be safely administered in high ... data were presented by Dr. Anthony Tolcher, Director,of ...
... - Studies Show Improvement in Hemodynamics and Delay ... Actelion Pharmaceuticals US, Inc.,today announced positive results from ... and effective as a combination therapy,for the treatment ... suggest that Tracleer, when given in combination with ...
Cached Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
2-ply material consisting of polyethylene film inner layer and non-woven outer layers....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass....
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
Medicine Products: